WP 2

WP 2: Organisation of a workshop on clinical audit of radiology, radiotherapy, and nuclear medicine practice.

WP 2 was responsible for organising a workshop with the goal of discussing the state of play of clinical audit in the EU with representatives of Member States and raising awareness about the legal requirements and the benefits of clinical audit in diagnostic and interventional radiology, nuclear medicine and radiotherapy.

The workshop was run as a series of webinars from 14-16 December 2020. The workshop programme can be viewed here: QuADRANT Workshop programme. Invitations to the workshop were made based on the results of the WP 3 pre-survey.

The slides from presentations given during the webinars can be viewed below:

Webinar 1, 14th December 2020
SETTING THE SCENE
Georgi Simeonov (Policy Officer, Radiation Protection and Nuclear Safety in DG ENER, European Commission)

AN INTRODUCTION TO THE QUADRANT PROJECT
David Howlett (Project Leader, Chair of the ESR Audit and Standards Subcommittee and former-chair of the UK Royal College of Radiologists (RCR) Clinical Audit and Quality Improvement Committee)

CLINICAL AUDIT AS DEFINED IN THE EUROPEAN BASIC SAFETY STANDARDS DIRECTIVE
Alexandra Karoussou-Schreiner (Chair of HERCA Working Group – Medical Applications)

CLINICAL AUDIT & QUALITY IMPROVEMENT
Adrian Brady (Project Co-Leader, ESR 2nd Vice President)

INTERNATIONAL ATOMIC ENERGY AGENCY EXPERIENCE OF CLINICAL AUDIT: QUAADRIL, QUANUM AND QUATRO PROJECTS
Diana Paez (Section Head, Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency)

WORLD HEALTH ORGANIZATION EXPERIENCE OF CLINICAL AUDIT
Shamsuzzoha Babar Syed (Coordinator, Quality of Care Unit, World Health Organization)

Webinar 2, 15th December 2020
AIMS AND BENEFITS OF AUDIT BY SPECIALTY: RADIOLOGY
Boris Brkljacic (Chairman of the European Society of Radiology Board of Directors)

AIMS AND BENEFITS OF AUDIT BY SPECIALTY: NUCLEAR MEDICINE
Wim Oyen (President of the European Association of Nuclear Medicine)

AIMS AND BENEFITS OF AUDIT BY SPECIALTY: RADIOTHERAPY
Primoz Strojan (project team, Institute of Oncology Ljubljana, Slovenia)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE BELGIAN EXPERIENCE (PART 1)
Nils Reynders-Frederix (Belgian Federal Public Service for Public Health)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE BELGIAN EXPERIENCE (PART 2)
Marleen Vandecapelle (Belgian Federal Agency for Nuclear Control)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE BELGIAN EXPERIENCE (PART 3)
Aude Vaandering (Department of Radiation Oncology, Cliniques Universitaires St Luc, Brussels)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE FINNISH EXPERIENCE
Raija Seuri (Helsinki University Hospital)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE SWISS EXPERIENCE
Carine Galli Marxer (Swiss Federal Office of Public Health)

Webinar 3, 16th December 2020
NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE UNITED KINGDOM’S EXPERIENCE (PART 1)
Danny Keenan (Medical Director of the Health and Quality Improvement Partnership)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE UNITED KINGDOM’S EXPERIENCE (PART 2)
Rebecca Greenhalgh (Chair of the Royal College of Radiologists’ Audit and Quality Improvement Committee)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE LUXEMBOURG EXPERIENCE
Alexandra Karoussou-Schreiner (Medical Physics Expert, Luxembourg Ministry of Health)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE NORWEGIAN EXPERIENCE
Ingrid Bjørseth Heikkilä (Head of Section, Medical Applications, The Norwegian Radiation and Nuclear Safety Authority)

NATIONAL EXPERIENCE OF CLINICAL AUDIT: THE SLOVAKIAN EXPERIENCE
Denisa Nikodemová (Faculty of Public Health, Slovak Medical University, Bratislava) & Martina Horváthová (Faculty of Health Care and Social Work, Trnava University)

THE CLINICAL AUDIT EXPERIENCE OF EUROPEAN UNION OF MEDICAL SPECIALISTS/EUROPEAN BOARD OF NUCLEAR MEDICINE
John Prior (Chair, European Union of Medical Specialists/European Board of Nuclear Medicine Accreditation of Nuclear Medicine Departments and Nuclear Medicine Training Centres)

INTRODUCTION OF QUADRANT WORK PACKAGE 3 SURVEY & NEXT STEPS IN THE QUADRANT PROJECT
David Howlett (Project Leader, Chair of the ESR Audit and Standards Subcommittee)

 

During the webinars, a call was put out to other countries or organizations that wished to share their experience of clinical audit. The following posters were received in response to this call:

The International Atomic Energy Agency’s Role in Quality Assurance Processes

Clinical Audit in France

Analysis of Conditions for Mamographic Screening Implementation in the Slovak Republic for Early Breast Cancer Detection

 

WP Leader: M. Brada
Co-Leaders: A. Brady & W. Wadsak

WP 2 was in charge of the following tasks:

Task 2.1         Establishing the programme structure, and defining invited presentations and speakers, and panel discussions. The Project Office is in charge of promotion and dissemination activities for the workshop.

Task 2.2         Organisational arrangements – due to COVID-19 restrictions the workshop was held as a series of webinars, rather than the face-to-face meeting originally envisaged.

Task 2.3         Preparation of proceedings of the workshop including the number and type of sessions, lecturers, duration, number of participants, general structure, and the main workshop conclusions and recommendations for further action.